Congenica
UKCongenica is a biotech company, headquartered in UK.
Entry
2015
Hold
10yr
Exit
2025
Est. EV
–
Who owns Congenica?
Congenica was owned by Cambridge Innovation Capital through CIC Fund II (2022 vintage) from 2015 to 2025, exited via Trade Sale. Across its history, Congenica has been through 2 private equity ownership periods, detailed in the timeline below.
Buyer identity available on Pro.
Hand-verified · updated 2026-07-07
Most recent investor
Cambridge Innovation CapitalCIC Fund II · 2022 · VC
2 ownership periods · full history below
Key facts
HQUK
SectorBiotech
StatusAcquired
Key takeaways
- ·Fully exited in 2025.
- ·Average hold across 2 realized cycles: 11 years.
Ownership history
2 ownership periods · co-invest detected
Exited
Last exited in 2025 to .
Co-invest · 2 holders · 2014 · 2025
Amadeus Capital PartnersExited 2025
2014 · 2025 · Amadeus IV Digital Prosperity Fund · 2013 · Growth
Trade Sale · to
MOIC
–
More from CIC Fund II
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
France
BelgiumData refreshed weekly · Sourced from public filings